Verily announced a multi-year strategic collaboration with UCHealth, the University of Colorado Anschutz Medical Campus, and RefinedScience aimed at transforming the use of biomedical data and redefining how patient care is delivered. This partnership leverages Verily’s expertise in healthcare technology…
Muse S Athena, the world’s first consumer device to integrate EEG and fNIRS advanced sensor technologies, has quickly emerged as Muse’s most sought-after product. Since its launch, it has sold out multiple times, earning adoption from both individual consumers and…
Syncell Inc., a pioneering company in next-generation unbiased subcellular proteomics, has announced the deployment of its commercial Microscoop® Mint technology at two of Europe’s most prestigious research institutes renowned for proteomics and advanced technology adoption. The Max Planck Institute of…
Pilatus Biosciences Inc., a biopharmaceutical company pioneering metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, announced the issuance of its foundational patent in Europe and Australia titled “Methods for Modulating Regulatory T Cells and Inhibiting Tumor Growth.” This milestone marks…
Echo, a global leader in hydrogen wellness technology, has highlighted new research that strengthens the case for molecular hydrogen (H₂) as a powerful aid in lung recovery and inflammation reduction following high-intensity exercise. The study, recently published in the Journal…
Ascribe Bio, a pioneer in natural crop protection technologies, announced the successful closing of a $12 million oversubscribed Series A financing round, co-led by Corteva, through its Corteva Catalyst platform, and Acre Venture Partners. The funding round also saw participation…
Nurea, a leader in AI-driven medical imaging innovation, has announced that its PRAEVAorta®2 software has received FDA 510(k) clearance, paving the way for its introduction into the U.S. healthcare market. The clearance marks a pivotal step in transforming the way…
Oticara, a clinical-stage pharmaceutical company focused on developing innovative therapies for chronic rhinosinusitis (CRS), announced encouraging results from its Phase 2 OT-007B clinical trial. The study evaluated Oticara’s proprietary nasal-mucosa-optimized steroid cream in patients suffering from persistent CRS symptoms after…
Alzheon, Inc., a clinical-stage biopharmaceutical company advancing novel therapies and diagnostics for Alzheimer’s disease (AD) and other neurodegenerative disorders, announced the peer-reviewed publication of its pivotal APOLLOE4 Phase 3 trial results in Drugs, a leading scientific journal. The paper, titled…
Wiley, a global leader in research intelligence and academic publishing, has launched Wiley AI Gateway, an innovative AI-native research intelligence platform designed to connect researchers, publishers, and AI systems through a single, trusted access point. This marks a major milestone…